Financial & competing interests disclosure
This work was supported in part by grants from the Dotan Hematology Center at Tel Aviv University, The Lewis Family Trust, Israel Science Foundation (award #181/10), the ICORE Program of the Planning and Budgeting Committee and The Israel Science Foundation (grant number 41/11) FTA: Nanomedicines for Personalized Theranostics of the Israeli National Nanotechnology Initiative and by The Leona M. and Harry B. Helmsley Nanotechnology Research Fund awarded to D Peer. D Peer declares financial interests in Quiet Therapeutics. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.